Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
Tevogen Bio Holdings Inc. has regained compliance with Nasdaq's minimum $1.00 bid price requirement, ensuring continued listing on the Nasdaq Global Market. The company is progressing its integrated healthcare model combining immunotherapy, AI, and capital discipline, and is exploring strategic acquisitions to pivot towards a cash-flow-positive ope…